The decision should be justified by demonstrating that the remaining uncertainty has been scientifically evaluated and appropriately controlled, not by relying on the limitations of the analytical method. During regulatory review, inspectors spend very little time discussing why a lower reporting limit could not be achieved and considerably more time examining how the associated risk was assessed.

Inspection friction develops when analytical limitations become the primary justification for accepting an impurity. Reviewers expect to see evidence that process knowledge, impurity formation pathways, manufacturing controls, toxicological assessment, and available analytical data were evaluated together before the conclusion was reached. Simply documenting that an impurity was "below the method capability" rarely answers the questions that inspectors ask.

Documentation becomes much stronger when it explains why the available method remains fit for purpose, what alternative analytical approaches were considered, how process controls reduce uncertainty, and when improved analytical capability will be introduced. Decisions supported by a documented evaluation of uncertainty consistently withstand greater scrutiny than those supported primarily by analytical limitations.

A scientifically sound assessment becomes difficult to defend when reviewers cannot reconstruct how the final conclusion was reached. During inspections, questions often focus less on the scientific outcome than on whether the supporting rationale can be followed from beginning to end without relying on undocumented discussions or institutional knowledge.

Inspection concerns frequently arise when process development reports, toxicological evaluations, analytical studies, and quality records each tell part of the story but never establish a complete decision pathway. Statements such as "no additional concern identified" or "risk considered acceptable" provide little value unless the supporting evidence and reasoning are clearly documented.

Records carry greater weight when they explain why specific impurities were included or excluded, how manufacturing knowledge influenced the assessment, what evidence supported expert judgment, and how significant decisions were reviewed and approved. Documentation that allows an independent reviewer to understand every major decision without interpretation is considerably easier to defend than records requiring assumptions to fill the gaps.

A new assessment is warranted whenever the scientific assumptions supporting the original evaluation are no longer valid. The decision should be based on how the process change affects impurity formation, removal, or patient exposure rather than on the size of the manufacturing change itself.

Inspection discussions often begin when organizations treat process modifications as routine change control activities without examining whether new impurity pathways could have been introduced. Changes involving reagents, starting materials, reaction conditions, purification strategies, suppliers, or degradation behavior frequently alter the assumptions that supported previous conclusions. Reusing an earlier assessment without documenting why it remains applicable invites additional regulatory questions.

A defensible review compares the original process with the revised process and explains how each relevant change was evaluated. Process chemistry assessments, representative analytical data, updated impurity predictions, and documented toxicological review provide stronger evidence than repeating historical conclusions without demonstrating that the underlying scientific basis remains unchanged.

Consistent procedures do not always produce consistent decisions because individual functions often evaluate different pieces of the same scientific question. Regulatory reviewers frequently discover that process development, analytical laboratories, toxicology, quality, and regulatory affairs reached compatible conclusions independently but never documented a shared technical rationale.

Inspection concerns increase when one function updates its assessment after a manufacturing or analytical change while related evaluations remain unchanged elsewhere. Those disconnects create conflicting assumptions that are difficult to explain during review, even though each department complied with its own procedures.

Programs become substantially easier to defend when significant technical decisions are supported by documented ownership, defined review points, recorded scientific justification, and clear evidence that cross functional assumptions remain aligned. Inspectors place considerable confidence in decision records that show how technical evidence was evaluated collectively rather than documentation demonstrating that each department completed its assigned activities independently.